MyFinsight
Home
Blog
About
Cash and cash
equivalents
$182,478K
(22.00%↑ Y/Y)
Accounts receivable, net
$97,422K
(90.07%↑ Y/Y)
Prepaid expenses and
other current assets
$8,302K
(-43.21%↓ Y/Y)
Inventory
$7,713K
(124.80%↑ Y/Y)
Total current assets
$295,915K
(35.20%↑ Y/Y)
Inventory, non-current
$21,827K
(-11.54%↓ Y/Y)
Other long-term
assets
$3,088K
(82.40%↑ Y/Y)
Restricted cash
$2,864K
(0.07%↑ Y/Y)
Operating lease
right-of-use assets
$2,410K
(176.06%↑ Y/Y)
Property and equipment,
net
$971K
(-21.82%↓ Y/Y)
Total assets
$327,075K
(30.71%↑ Y/Y)
Accumulated deficit
-$1,532,209K
(-6.91%↓ Y/Y)
Total liabilities and
stockholders' deficit
$327,075K
(30.71%↑ Y/Y)
Total stockholders'
deficit
-$344,273K
(15.17%↑ Y/Y)
Additional paid-in capital
$1,187,928K
(15.64%↑ Y/Y)
Common stock, 0.0001
par value...
$8K
(33.33%↑ Y/Y)
Total liabilities
$671,348K
(2.33%↑ Y/Y)
Revenue interest
financing liability
$347,629K
(0.18%↑ Y/Y)
Long-term debt, net of
discount
$164,587K
(-19.77%↓ Y/Y)
Total current
liabilities
$153,777K
(67.47%↑ Y/Y)
Other long-term
liabilities
$3,500K
(-69.57%↓ Y/Y)
Operating lease
liabilities
$1,855K
(214.94%↑ Y/Y)
Accrued expenses
$109,027K
(69.57%↑ Y/Y)
Current portion of
revenue interest...
$37,283K
(73.20%↑ Y/Y)
Accounts payable
$5,361K
(33.76%↑ Y/Y)
Accrued interest
$1,436K
(-18.18%↓ Y/Y)
Operating lease
liabilities, current
$670K
(181.51%↑ Y/Y)
Back
Back
Balance Sheet
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)
source: myfinsight.com